glp-1 drug shortages Drugs Drop More Than Just Weight Addressing GLP-1 Access and Adherence

Tackling Obesity and Type 2 Diabetes: The extensive utilization of GLP-1 drugs could significantly impact the management and prevention of obesity and type 2 diabetes

Biological and functional characteristics of a novel lowmolecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, in vitro and in vivo

Support for GLP-1 Medication Effectiveness Lentils and chickpeas dont just provide nutrients they also complement GLP-1 medications

A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)

This overlap makes determining whether observed cases represent a true drug effect or reflect underlying patient susceptibility challenging